Dosing also diverged from the approved label. Regorafenib's standard dose (RSD) is an average daily dose of 160 mg for 21 days of a 28-day cycle, yet more than a quarter of patients (26.5%) were ...

However, the risk of these rare cancers is not enough to dissuade prescribing CAR T-cell therapy for CLL, explains Kerry Rogers, MD, The James.

New research: nearly one in three adults with private insurance are paying off medical debt. Commonwealth Fund. News release. September 17, 2026. Accessed September 16, 2026.

Vitamin K shot refusals among newborns in the US have risen 77%, from 2.92% in 2017 to 5.18% in 2024, leading clinicians interviewed for this piece to believe broader vaccine hesitancy may be ...

Oral GLP-1s, Medicare access, and lingering weight bias are reshaping obesity care, says NYU Langone's Holly Lofton, MD.

Holly F. Lofton, MD, is clinical associate professor of medicine and surgery and director of the Medical Weight Management Program at NYU Langone Health.

Differences in the memory B-cell compartment were measurable on the day antiviral therapy stopped, separating the patients with chronic hepatitis B who would go on to clear surfac ...

Employers can support better cancer outcomes by investing in innovative solutions that improve access, prevention, treatment, survivorship, and return-to-work support, Karen van Caulil, PhD, explained ...